NCT00142961View on ClinicalTrials.gov

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Attention Deficit Disorder With HyperactivityMarijuana Abuse
Interventions
DRUG

Atomoxetine

atomoxetine

OTHER

placebo

Trial Locations (1)

10032

Phoenix House, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00142961 - Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter